Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 13/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 14/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 12/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 11/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 11/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 9/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 9/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 9/20 | 0.48 |
| ▸ | HDAC9 | Q9UKV0 | 9/20 | 0.48 |
| ▸ | HDAC5 | Q9UQL6 | 9/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 8/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | NR0B1 | P51843 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7102450 | 0.89 | HDAC2 (0.58) | HDAC2KMT2ALTA4HMEN1POLB | |
| SCHEMBL8144564 | 0.85 | HDAC2 (1.00) | HDAC2HDAC8HDAC6HDAC3HDAC1 | |
| SCHEMBL8152490 | 0.85 | HDAC2 (1.00) | HDAC2HDAC8HDAC6HDAC3HDAC1 | |
| SCHEMBL3586401 | 0.84 | HDAC2 (0.69) | HDAC2HDAC8HDAC6HDAC3HDAC1 | |
| SCHEMBL3585137 | 0.84 | HDAC2 (0.69) | HDAC2HDAC8HDAC6HDAC3HDAC1 | |
| SCHEMBL3581645 | 0.84 | HDAC2 (0.69) | HDAC2HDAC8HDAC6HDAC3HDAC1 | |
| SCHEMBL3591236 | 0.84 | HDAC2 (0.69) | HDAC2HDAC8HDAC6HDAC3HDAC1 | |
| SCHEMBL3242251 | 0.84 | HDAC2 (0.97) | HDAC2HDAC8HDAC6HDAC3HDAC1 | |
| SCHEMBL13369426 | 0.83 | HDAC2 (0.68) | HDAC2KMT2AHDAC8HDAC6HDAC3 | |
| SCHEMBL7563463 | 0.83 | HDAC2 (0.68) | HDAC2KMT2AHDAC8HDAC6HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731199-A2 | COMPOSITIONS COMPRISING ANTINEOPLASTONS AND METHODS OF TREATING COLORECTAL CANCER | Burzynski, Stanislaw R. (US) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024263813-A2 | COMPOSITIONS COMPRISING ANTINEOPLASTONS AND METHODS OF TREATING COLORECTAL CANCER | BURZYNSKI STANISLAW R (US) | 2024-12-26 | — | — | WO | disclosed |
| CN-106061481-B | The combination of androgen receptor inhibitor and AKT inhibitor for treating cancer | 诺华股份有限公司 | 2019-08-16 | — | — | CN | disclosed |
| CN-109806266-A | Combination and its application use for cancer treatment | 诺华股份有限公司 | 2019-05-28 | — | — | CN | disclosed |
| CN-109674801-A | Combination | 诺华股份有限公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-109563043-A | SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1 | 葛兰素史密斯克莱知识产权发展有限公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-106456642-A | Combination comprising a btk inhibitor and an akt inhibitor | 诺华股份有限公司 | 2017-02-22 | — | — | CN | disclosed |
| WO-2015184260-A2 | METHODS FOR TREATING MENDELIAN DISORDERS OF THE EPIGENETIC MACHINERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-12-03 | — | — | WO | disclosed |
| CN-101909630-A | Methods and compounds for preventing and treating a tumour | AGENCY SCIENCE TECH & RES | 2010-12-08 | — | — | CN | disclosed |
| EP-2167090-A2 | HDAC INHIBITORS AND HORMONE TARGETED DRUGS FOR THE TREATMENT OF CANCER | University of Maryland, Baltimore (US) | 2010-03-31 | — | — | EP | disclosed |
| WO-2009126662-A1 | ADMINISTRATION OF AN INHIBITOR OF HDAC, AN INHIBITOR OF HER-2, AND A SELECTIVE ESTROGEN RECEPTOR MODULATOR | SYNDAX PHARMACEUTICALS, INC. (US) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009064300-A1 | COMBINATIONS OF HDAC INHIBITORS AND CYTOKINES/GROWTH FACTORS | THE JOHNS HOPKINS UNIVERSITY (US) | 2009-05-22 | — | — | WO | disclosed |
| WO-2008154402-A2 | HDAC INHIBITORS AND HORMONE TARGETED DRUGS FOR THE TREATMENT OF CANCER | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2008-12-18 | — | — | WO | disclosed |